BioInformatiCo (Pty) Ltd
Registration Number: 2023/005185/07
13th Floor, Green Park Corner, 3 Lower Road, Sandton, Johannesburg, Gauteng 2000, South Africa
This Beta Program Agreement governs your participation in testing Leova, BioInformatiCo’s clinical trial configuration platform. Leova processes clinical trial protocol documents and generates EDC configurations, schedules of events, eCRFs, and edit checks that can be exported to your chosen EDC system.
The purpose of this beta program is to evaluate Leova’s functionality and usability in a pre-commercial environment. You will test the platform with your own protocols, provide feedback on features and performance, and assess its potential fit for future use in your organization. This collaborative testing helps us refine the platform before commercial launch.
Leova is pre-production software designed to accelerate trial database configuration and build. As a configuration tool used at the start of trial setup, Leova generates EDC configurations that you then implement in your chosen EDC system. The platform is in beta testing, which means outputs should be reviewed by qualified personnel and thoroughly tested before implementing in your production EDC environment.
This agreement begins on the date of your acceptance and continues for an initial term of six months. We may extend the program by mutual written agreement. Either party may end participation with 30 days written notice.
When the beta program ends, you’ll have 90 days to export any data you’d like to keep. After this period, we’ll remove your data from our systems unless we’re legally required to retain it. Your confidentiality commitments and the liability provisions in this agreement remain in effect after termination.
You may access and use Leova for internal evaluation purposes. This includes uploading your clinical trial protocols, generating EDC configurations, testing features and functionality, using the reference library content, and providing feedback to help us improve the platform.
Leova is a configuration tool designed for trial setup and database build - it generates configurations that you implement in your production EDC system. Generated configurations should undergo appropriate review and testing before implementing in your production EDC environment.
BioInformatiCo retains full ownership of the Leova platform and all underlying technology, including software, algorithms, AI models, general reference library content, all improvements and modifications, and our trademarks and branding.
You retain full ownership of your clinical trial protocols, EDC configurations generated from your protocols, and custom library content you create within the platform.
You grant us the right to use de-identified protocol structures and patterns to train and improve our AI models, provided such use cannot reasonably identify you or your specific protocols. We will not disclose your specific protocols or identify you when using these learnings to improve the platform for all users.
Your confidential information includes clinical trial protocols, research strategies, generated EDC configurations, and anything you mark as confidential. Our confidential information includes Leova’s architecture, algorithms, source code, methodologies and processes, business strategies and roadmaps, and anything we mark as confidential.
Both parties agree to keep confidential information secret, use it only for this beta program, and protect it with reasonable security measures. Confidentiality obligations last for three years after the beta program ends, except for trade secrets which remain confidential indefinitely.
BioInformatiCo acts as a data processor for any personal data in your protocols, while you are the data controller. You are responsible for ensuring you have legal basis to upload such data under applicable privacy laws including GDPR and POPIA.
We implement appropriate technical and organizational security measures to protect your data, including encryption in transit and at rest. Your data is hosted on secure cloud infrastructure with appropriate compliance certifications.
Leova is provided “as is” and “as available” without warranties of any kind. We specifically disclaim all warranties including merchantability, fitness for a particular purpose, and accuracy. The beta software should not be relied upon as the sole basis for regulatory submissions without appropriate review.
BioInformatiCo’s total liability for anything related to this agreement is capped at 10,000 euros. Neither party is liable for indirect, incidental, special, consequential, or punitive damages.
This agreement is governed by South African law. Any disputes will first be addressed through good-faith negotiation for 30 days. If negotiation fails, jurisdiction lies with the courts of Gauteng, South Africa.
By clicking “I Accept,” you acknowledge that you have read and understand this Beta Program Agreement, agree to be bound by all terms and conditions, and have authority to bind your organization.